Related Articles |
Rituximab: a novel therapy for refractory Riedel’s thyroiditis.
Endocrinol Diabetes Metab Case Rep. 2018;2018:
Authors: Hunt L, Harrison B, Bull M, Stephenson T, Allahabadia A
Summary
This case report opinions the uncommon situation of Riedel’s thyroiditis by way of a affected person case. The report highlights the difficulties that one might encounter when managing such a case with regard to affected person signs, unwanted effects of medicines and the relapsing nature of the situation. The case report additionally highlights novel therapy within the therapy of Riedel’s thyroiditis, rituximab, how this works and the decision of signs that we have now achieved with our affected person on this therapy.
Studying factors: Riedel’s thyroiditis is characterised by continual irritation, which causes dense fibrosis within the thyroid gland.Riedel’s thyroiditis can current with neck ache, dysphagia and dyspnoea with a agency, non-tender mass discovered on examination.Riedel’s thyroiditis is a part of the IgG4-related systemic problems.Rituximab is a monoclonal antibody that works towards the protein CD20.
PMID: 29472985 [PubMed]